BioAmber Inc.

Equities

BIOAQ

US09072Q1067

Delayed OTC Markets Other stock markets 03:58:57 2019-11-21 pm EST			5-day change	1st Jan Change
0.0525 ^USD	-8.30%		+17.98%	+609.46%

2018	LCY Chemical Corp. and Visolis Inc completed the acquisition of certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc.	CI
2018	LCY Chemical Corp. and Visolis Inc agreed to acquire certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc. for $4.3 million.	CI

BioAmber Inc. announced that it expects to receive $0.20 million in funding

August 07, 2017

BioAmber Inc. (NYSE:BIOA) announced that it has entered into a subscription agreement for a private placement of 273,331 common shares at a price of $0.75 per share for gross proceeds of $204,998 with certain of the company’s officers and directors on August 8, 2017. The transaction will involve participation from Chief Executive Officer, Chief Financial Officer, and certain directors. The transaction is expected to close on or about August 15, 2017.

Latest news about BioAmber Inc.

LCY Chemical Corp. and Visolis Inc completed the acquisition of certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc.	18-10-21	CI
LCY Chemical Corp. and Visolis Inc agreed to acquire certain assets of BioAmber Inc., BioAmber Canada Inc. and BioAmber Sarnia Inc. for $4.3 million.	18-09-13	CI
BioAmber Inc. Announces Management Resignations	18-09-04	CI
BioAmber Inc. Announces Resignation of Directors and Officers	18-08-31	CI
BioAmber Updates On Sales Process	18-07-30	CI
BioAmber Inc. Bankruptcy Case Dismissed	18-06-20	CI
Motion for Case Dismissal Filed for BioAmber Inc.	18-05-30	CI
BioAmber Inc. Filed for Bankruptcy	18-05-04	CI
BioAmber Inc. Auditor Raises 'Going Concern' Doubt	18-03-29	CI
Transcript : BioAmber Inc., Q4 2017 Earnings Call, Mar 28, 2018	18-03-28
BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Year and Sales Results for the Fourth Quarter Ended December 31, 2017; Announces Impairment for the Fourth Quarter Ended December 31, 2017	18-03-27	CI
BioAmber Inc.(OTCPK:BIOA) dropped from S&P TMI Index	18-02-13	CI
Transcript : BioAmber Inc., Q3 2017 Earnings Call, Nov 07, 2017	17-11-07
BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter Ended September 30, 2017; Provides Sales Guidance for the Fourth Quarter of 2017	17-11-07	CI
BioAmber Inc. Announces Resignation of Fabrice Orecchioni as President and Chief Operating Officer	17-10-24	CI
Bioamber Inc. Announces the Appointment of Richard P. Eno as Its New Chief Executive Officer and New Member of the Board, Effective September 18, 2017	17-09-14	CI
BioAmber Inc. announced that it has received $0.20 million in funding	17-08-14	CI
BioAmber Inc. announced that it expects to receive $0.20 million in funding	17-08-07	CI
Transcript : BioAmber Inc., Q2 2017 Earnings Call, Aug 03, 2017	17-08-03
BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2017	17-08-03	CI
BioAmber Inc. (NYSE:BIOA; TSX:BIOA) acquired the remaining 38.9% stake in BioAmber Sarnia Inc. from Mitsui & Co., Ltd. for a nominal consideration of CAD 1.	17-08-02	CI
Bioamber Inc. Announce the Launch of BIO-SATM pharmaceutical grade	17-06-15	CI
BioAmber Inc. Announces Management Changes	17-05-15	CI
Transcript : BioAmber Inc., Q1 2017 Earnings Call, May 09, 2017	17-05-09
BioAmber Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2017	17-05-09	CI

Chart BioAmber Inc.

Duration

Period

More charts

Company Profile

BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.

Sector

More about the company